{"id":"W3140838881","doi":"10.1016/j.eururo.2021.03.014","title":"Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab","year":2021,"lang":"en","type":"article","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"ca_institutions":"Decipher Biosciences (Canada); University of British Columbia","funders":"","keywords":"Pembrolizumab; Medicine; Cystectomy; Bladder cancer; Oncology; Internal medicine; Cohort; Neoadjuvant therapy; Pathology; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005895509,0.0001337489,0.0002472531,0.00005714432,0.00002100758,0.000006260694,0.00005551023,0.00004872817,0.001373952],"category_scores_gemma":[0.00002733078,0.0001209187,0.00007525972,0.0001191055,0.0000670304,0.00003395585,0.00006191277,0.0001209483,0.00009448893],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002176179,"about_ca_system_score_gemma":0.0001488042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001573926,"about_ca_topic_score_gemma":0.000006031041,"domain_scores_codex":[0.9989215,0.0002048632,0.0002355746,0.000286365,0.0001449544,0.0002068126],"domain_scores_gemma":[0.9993896,0.00001146388,0.00007219377,0.0003046465,0.0001390637,0.00008306054],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002278719,0.0004261493,0.02489083,0.00008436762,0.0005616986,0.005776338,0.0008147046,0.00001421676,0.9494976,0.0002395363,0.0005344533,0.0148814],"study_design_scores_gemma":[0.003414555,0.0005823086,0.8736057,0.0000317,0.000441896,0.0002821663,0.00001391263,0.00002020082,0.09275233,0.00002560851,0.02867166,0.0001579463],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810293,0.001341252,0.0001838999,0.001970713,0.0002530439,0.0001414318,0.00006186173,0.00003687382,0.01498166],"genre_scores_gemma":[0.993864,0.0002136968,0.00006559682,0.004043286,0.0002371509,0.00001701325,0.0001091364,0.00004883314,0.001401275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8567452,"threshold_uncertainty_score":0.9995389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01077988165269376,"score_gpt":0.2584130071316301,"score_spread":0.2476331254789364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}